Bluebird Bio Investor
Bluebird Bio is a biopharma company that develops and commercializes gene therapies for the treatment of severe genetic diseases and cancer.
Technology:
CAR-T, Cell_Therapies
Industry:
Gene therapy, Public
Headquarters:
Somerville, Massachusetts, United States
Founded Date:
1993-01-01
Employees Number:
501-1000
Funding Status:
IPO
Investor Type:
N/A
Investment Stage:
N/A
Number Of Exits:
1
Investors Number:
13
Total Funding:
593350000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2023-01-18
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership